Levlen
Levlen is designed to support pregnancy prevention through consistent daily hormone administration.
Strengths: 0.03/0.15mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Microgynon 30; Rigevidon; Alesse
- Therapeutic class
Combined Oral Contraceptive
- Pharmacological class
Oestrogen and Progestogen
- Minor side effects
headache; nausea; breast tenderness; spotting
- Moderate side effects
mood changes; weight changes; libido reduction; chloasma
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Bayer
- Onset Time
1–2 weeks
- Duration
24 hours
- Storage instructions
Store in a cool, dry place.
- Drug interactions
Ritonavir; Bosentan; Felbamate
- Age restrictions
For women of reproductive capability.
- Pregnancy and breastfeeding
Pregnancy: Contraindicated. Breastfeeding: Avoid use.
Contraindications
history of venous thromboembolism; ischaemic heart disease; migraine with aura; diabetes with vascular complications
Precautions and warnings
discontinue if signs of thrombosis occur; evaluate risk-benefit ratio in smokers over 35
Serious side effects
myocardial infarction — requires immediate medical attention; thrombosis — requires immediate medical attention; cervical neoplasia — requires immediate medical attention
Patient summary
Levlen is designed to support pregnancy prevention through consistent daily hormone administration.
Mechanism of action
A combination of oestrogen and progestogen that inhibits ovulation by creating negative feedback on the hypothalamic-pituitary axis, which suppresses gonadotrophin release.
Levlen
Levlen is designed to support pregnancy prevention through consistent daily hormone administration.
Editorial Notes
- Active ingredient(s): Ethinylestradiol, Levonorgestrel
- Listed indication(s): Contraception
Available option
- 189 tablets - 0.03/0.15 mg466-0-03-0-15-mg-1223